Movement disorders and nonmotor neuropsychological symptoms in children and adults with classical galactosemia. Issue 3 (27th February 2019)

• Record Type: Journal Article
• Authors: Kuiper, Anouk; Grünewald, Stephanie; Murphy, Elaine; Coenen, Maraike A.; Eggink, Hendriekje; Zutt, Rodi; Rubio‐Gozalbo, Maria E.; Bosch, Annet M.; Williams, Monique; Derks, Terry G. J.; Lachmann, Robin H. L.; Brouwers, Martijn C. G. J.; Janssen, Mirian C. H.; Tijssen, Marina A.; de Koning, Tom J.
• Is Part Of: Journal of inherited metabolic disease. Volume 42:Issue 3(2019)
• Page Start: 451
• Page End: 458
• Publication Date: 2019-02-27
• Subjects: galactosemia -- dystonia -- tremor -- daily functioning -- nonmotor symptoms; Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1002/jimd.12054
• Languages: English
• ISSNs: 0141-8955

Abstract

Abstract: Although movement disorders (MDs) are known complications, the exact frequency and severity remains uncertain in patients with classical galactosemia, especially in children. We determined the frequency, classification and severity of MDs in a cohort of pediatric and adult galactosemia patients, and assessed the association with nonmotor neuropsychological symptoms and daily functioning. Patients from seven centers in the United Kingdom and the Netherlands with a confirmed galactosemia diagnosis were invited to participate. A videotaped neurological examination was performed and an expert panel scored the presence, classification and severity of MDs. Disease characteristics, nonmotor neuropsychological symptoms, and daily functioning were evaluated with structured interviews and validated questionnaires (Achenbach, Vineland, Health Assessment Questionnaire, SIP68). We recruited 37 patients; 19 adults (mean age 32.6 years) and 18 children (mean age 10.7 years). Subjective self‐reports revealed motor symptoms in 19/37 (51.4%), similar to the objective (video) assessment, with MDs in 18/37 patients (48.6%). The objective severity scores were moderate to severe in one third (6/37). Dystonia was the overall major feature, with additional tremor in adults, and myoclonus in children. Behavioral or psychiatric problems were present in 47.2%, mostly internalizing problems, and associated with MDs. Daily functioning was significantly impaired in the majority of patients. Only one patient received symptomatic treatment for MDs. We show that MDs and nonmotor neuropsychological symptoms are frequent in both children and adults with classical galactosemia.